A number of other equities analysts also recently commented on AFX. Deutsche Bank Aktiengesellschaft set a €156.00 ($159.18) price objective on shares of Carl Zeiss Meditec in a research report on Monday, August 8th. UBS Group set a €170.00 ($173.47) price objective on shares of Carl Zeiss Meditec in a research report on Friday, August 5th. Finally, Hauck Aufhäuser Investment Banking set a €195.00 ($198.98) price objective on shares of Carl Zeiss Meditec in a research report on Tuesday, September 13th.
Carl Zeiss Meditec Stock Down 5.2 %
Shares of ETR:AFX opened at €107.00 ($109.18) on Thursday. The stock has a market cap of $9.57 billion and a P/E ratio of 41.20. The firm has a fifty day moving average price of €129.94 and a 200 day moving average price of €127.78. The company has a debt-to-equity ratio of 6.84, a current ratio of 3.35 and a quick ratio of 2.62. Carl Zeiss Meditec has a 1-year low of €104.55 ($106.68) and a 1-year high of €202.00 ($206.12).
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.